A major advance in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This crucial malignant protector protein is frequently inactivated in several forms of cancer, resulting https://bookmarkcolumn.com/story21734871/mini-antibodies-reactivate-p53-the-new-approach-for-cancer-management